ANSUN BIOPHARMA, INC.

Profile

Company Names

ANSUN BIOPHARMA, INC.
NEXBIO, INC

Addresses

3030 CALLAN ROAD, SUITE 200, SAN DIEGO, CA 92121

3030 CALLAN ROAD, SUITE 200, SAN DIEGO, CA 92121

10665 SORRENTO VALLEY ROAD, SAN DIEGO, CA 92121

Phone Numbers

8584522631

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER

Year Incorporated:

> 5 years ago

State Incorporated:

CALIFORNIA

Total Amount Raised:

$195,138,386.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2019-07-17 
$100,000,000.00 
$100,000,000.00 
$0.00 
Equity 
6
2018-04-19 
$67,088,386.00 
$67,088,386.00 
$0.00 
Equity 
5
2017-02-24 
$1,650,000.00 
$1,650,000.00 
$0.00 
Debt 
4
2015-11-18 
$4,000,000.00 
$10,000,000.00 
$6,000,000.00 
Equity 
3
2014-05-13 
$7,500,000.00 
$17,900,000.00 
$10,400,000.00 
Equity 
2
2013-04-25 
$5,000,000.00 
$24,275,430.00 
$19,275,430.00 
Equity 
1
2010-11-28 
$9,900,000.00 
$16,000,000.00 
$6,100,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARK 
 
ATTEBURY 
EXECUTIVE OFFICER
NANCY 
 
CHANG 
DIRECTOR, EXECUTIVE OFFICER
ALLEN 
 
CHAO 
DIRECTOR
MICHAEL 
 
CHAO 
EXECUTIVE OFFICER, DIRECTOR
DAVE 
 
CHENN 
DIRECTOR
MICHAEL 
 
HAVLUCIYAN 
EXECUTIVE OFFICER
MIKAEL 
 
HAVLUCIYAN 
EXECUTIVE OFFICER
RON 
 
MOSS 
EXECUTIVE OFFICER
RONALD 
 
MOSS 
EXECUTIVE OFFICER
DONALD 
 
PAYNE 
DIRECTOR
YI 
 
SHI 
DIRECTOR
AIMIN 
 
WU 
DIRECTOR
SHI 
 
YI 
DIRECTOR
YINING 
 
ZHAO 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-17 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-17 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-19 
D
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2017-02-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-11-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CHINA RENAISSANCE SECURITIES (US) INC.